Chongqing Lummy Pharmaceutical (300006) — Cash Flow Reinvestment Rate
Chongqing Lummy Pharmaceutical (300006) has a Cash Flow Reinvestment Rate of 0.79x as of June 2025, reinvesting CN¥32.60 Million (capex CN¥7.00 Million plus investments CN¥25.60 Million) from operating cash flow of CN¥41.27 Million. Check 300006 cash flow quality index to evaluate the quality of earnings relative to operating cash generation.
Reinvestment Rate
Total Reinvested
Operating Cash Flow
Capital Expenditures
Chongqing Lummy Pharmaceutical Cash Flow Reinvestment Rate (2006–2024)
Historical reinvestment intensity for Chongqing Lummy Pharmaceutical across 17 annual periods. Explore long-term investment intensity of Chongqing Lummy Pharmaceutical to see how much of total assets are deployed in long-term investments.
Annual Cash Flow Reinvestment Rate for Chongqing Lummy Pharmaceutical (2006–2024)
Year-by-year capital reinvestment analysis for Chongqing Lummy Pharmaceutical. For live market cap and broader valuation context, see market cap of Chongqing Lummy Pharmaceutical.
| Year | Reinvestment Rate | Total Reinvested (CNY) | Operating CF | Capex | YoY Change |
|---|---|---|---|---|---|
| 2024 | 0.43x | CN¥79.71 Million | CN¥185.03 Million | CN¥75.51 Million | ▼ -81.2% |
| 2023 | 2.29x | CN¥186.43 Million | CN¥81.53 Million | CN¥59.32 Million | ▼ -12.0% |
| 2022 | 2.60x | CN¥148.38 Million | CN¥57.13 Million | CN¥68.18 Million | ▲ +83.9% |
| 2021 | 1.41x | CN¥152.95 Million | CN¥108.28 Million | CN¥38.66 Million | ▲ +171.0% |
| 2020 | 0.52x | CN¥117.04 Million | CN¥224.54 Million | CN¥43.58 Million | ▲ +12.2% |
| 2019 | 0.46x | CN¥107.47 Million | CN¥231.30 Million | CN¥63.07 Million | ▼ -73.9% |
| 2018 | 1.78x | CN¥402.62 Million | CN¥225.89 Million | CN¥125.93 Million | ▼ -14.7% |
| 2017 | 2.09x | CN¥128.34 Million | CN¥61.39 Million | CN¥21.23 Million | ▲ +1.3% |
| 2016 | 2.06x | CN¥259.43 Million | CN¥125.66 Million | CN¥76.98 Million | ▼ -56.6% |
| 2013 | 4.76x | CN¥355.40 Million | CN¥74.70 Million | CN¥355.40 Million | ▼ -51.2% |
| 2012 | 9.75x | CN¥177.33 Million | CN¥18.18 Million | CN¥177.33 Million | ▼ -14.4% |
| 2011 | 11.40x | CN¥135.10 Million | CN¥11.85 Million | CN¥135.10 Million | ▲ +333.8% |
| 2010 | 2.63x | CN¥98.97 Million | CN¥37.66 Million | CN¥98.97 Million | ▲ +423.9% |
| 2009 | 0.50x | CN¥18.74 Million | CN¥37.35 Million | CN¥18.74 Million | ▼ -65.5% |
| 2008 | 1.46x | CN¥25.10 Million | CN¥17.25 Million | CN¥25.10 Million | ▲ +71.2% |
| 2007 | 0.85x | CN¥18.43 Million | CN¥21.68 Million | CN¥18.43 Million | ▼ -57.5% |
| 2006 | 2.00x | CN¥15.54 Million | CN¥7.77 Million | CN¥15.54 Million | — |